MARTINI, Maurizio
 Distribuzione geografica
Continente #
AS - Asia 3.315
NA - Nord America 2.971
EU - Europa 2.035
SA - Sud America 1.403
AF - Africa 97
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 9.825
Nazione #
US - Stati Uniti d'America 2.885
SG - Singapore 1.893
BR - Brasile 1.251
IE - Irlanda 547
HK - Hong Kong 488
IT - Italia 464
CN - Cina 445
SE - Svezia 333
VN - Vietnam 172
DE - Germania 145
RU - Federazione Russa 131
PL - Polonia 67
AT - Austria 64
ID - Indonesia 62
AR - Argentina 57
FI - Finlandia 57
FR - Francia 50
NL - Olanda 48
GB - Regno Unito 46
CA - Canada 38
ZA - Sudafrica 37
IN - India 34
TR - Turchia 31
BD - Bangladesh 30
MX - Messico 29
EC - Ecuador 25
IQ - Iraq 23
UZ - Uzbekistan 23
UA - Ucraina 20
VE - Venezuela 20
MA - Marocco 18
CO - Colombia 14
JP - Giappone 13
KE - Kenya 11
PK - Pakistan 11
PY - Paraguay 11
AZ - Azerbaigian 10
ES - Italia 10
CZ - Repubblica Ceca 9
PE - Perù 9
AE - Emirati Arabi Uniti 8
CI - Costa d'Avorio 8
EG - Egitto 8
JO - Giordania 8
KZ - Kazakistan 8
UY - Uruguay 8
OM - Oman 7
AL - Albania 6
KG - Kirghizistan 6
BH - Bahrain 5
IL - Israele 5
JM - Giamaica 5
LT - Lituania 5
RS - Serbia 5
BE - Belgio 4
BN - Brunei Darussalam 4
DO - Repubblica Dominicana 4
GE - Georgia 4
LB - Libano 4
NO - Norvegia 4
SN - Senegal 4
TN - Tunisia 4
TW - Taiwan 4
AO - Angola 3
BG - Bulgaria 3
BO - Bolivia 3
CH - Svizzera 3
CL - Cile 3
HU - Ungheria 3
NP - Nepal 3
RO - Romania 3
SA - Arabia Saudita 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BB - Barbados 2
BY - Bielorussia 2
DZ - Algeria 2
GR - Grecia 2
LK - Sri Lanka 2
PR - Porto Rico 2
SV - El Salvador 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
DK - Danimarca 1
GY - Guiana 1
HN - Honduras 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MZ - Mozambico 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 9.824
Città #
Dublin 547
Singapore 543
Ashburn 490
Hong Kong 482
Dallas 378
Nyköping 296
Chandler 257
Princeton 240
Medford 204
Messina 190
Beijing 119
São Paulo 99
Los Angeles 98
Buffalo 73
Moscow 65
Warsaw 61
Munich 57
Jakarta 56
Redondo Beach 53
Ho Chi Minh City 49
The Dalles 46
Belo Horizonte 40
Nuremberg 40
Hanoi 36
Rio de Janeiro 36
Frankfurt am Main 33
Vienna 33
New York 29
Amsterdam 26
Brasília 25
Milan 25
Porto Alegre 25
Santa Clara 25
Turku 25
Stockholm 24
Des Moines 23
Johannesburg 23
Catania 22
Guangzhou 22
Lappeenranta 22
Tashkent 22
Montreal 19
Rome 19
Brooklyn 18
Council Bluffs 18
Curitiba 17
Xi'an 16
San Francisco 15
Campo Grande 14
Chennai 14
Mexico City 13
São José dos Campos 13
Tokyo 13
Denver 12
Dong Ket 12
London 12
Salvador 12
Santo André 12
Boston 11
Campinas 11
Chicago 11
Seattle 11
Ankara 10
Baku 10
Fortaleza 10
Helsinki 10
Paris 10
Pelotas 10
Quito 10
Xiamen 10
Baghdad 9
Caxias do Sul 9
Guarulhos 9
Manchester 9
Tianjin 9
Toronto 9
Wilmington 9
Abidjan 8
Boardman 8
Duque de Caxias 8
Haiphong 8
Istanbul 8
Joinville 8
Nairobi 8
Newark 8
Ribeirão Preto 8
Sorocaba 8
Sumaré 8
Amman 7
Da Nang 7
Florence 7
Goiânia 7
Groningen 7
Guayaquil 7
Itajaí 7
Phoenix 7
Prineville 7
Springfield 7
Asunción 6
Bishkek 6
Totale 5.565
Nome #
Overexpression of PRV-1 gene in polycythemia rubra vera and essential thrombocythemia 171
Mutations of CD79A, CD79B and EZH2 genes in immunodeficiency-related non-Hodgkin lymphomas 165
Short communication: proangiogenic hematopoietic cells in acute HIV infection 164
Mutations of the BIK gene in human peripheral B-cell lymphomas 162
Aggressive variants of follicular cell-derived thyroid carcinoma: an overview 127
A Risk Score Based on 5 Clinico-Pathological Variables Predicts Recurrence of Atypical Meningiomas 107
A large series of hyalinizing trabecular tumors: Cytomorphology and ancillary techniques on fine needle aspiration 100
Analysis of immunocytochemical and molecular BRAF expression in thyroid carcinomas: A cytohistologic institutional experience. 90
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors 87
Well-differentiated thyroid cancer with a minor poorly differentiated component: clonal heterogeneity through the prognostic role of CXCR4 and BRAF analysis 86
Upper urothelial tract high-grade carcinoma: comparison of urine cytology and DNA methylation analysis in urinary samples 85
Retzius-sparing vs. standard robot-assisted radical prostatectomy for clinically localised prostate cancer: a comparative study 83
Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: new insights 83
ADAR1 is a new target of METTL3 and plays a pro-oncogenic role in glioblastoma by an editing-independent mechanism 82
Autophagic-Related Proteins in Brain Gliomas: Role, Mechanisms, and Targeting Agents 82
The Role of CD56 in Thyroid Fine Needle Aspiration Cytology: A Pilot Study Performed on Liquid Based Cytology 82
Role of IL-33/ST2 Pathway in Inflammatory Bowel Disease: An Overview and Future Perspectives 81
Noninvasive follicular thyroid neoplasm with papillary-like nuclear features in the pediatric age group 81
BRAF-AXL-PD-L1 Signaling Axis as a Possible Biological Marker for RAI Treatment in the Thyroid Cancer ATA Intermediate Risk Category 80
A multi-surgeon learning curve analysis of overall and site-specific positive surgical margins after RARP and implications for training 79
Bone marrow megakaryocytic activation predicts fibrotic evolution of Philadelphia-negative myeloproliferative neoplasms 74
A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor 71
Rare histotypes of epithelial biliary tract tumors: A literature review 71
Immunohistochemical Profile of p62/SQSTM1/Sequestosome‐1 in Human Low‐ and High‐Grade Intracranial Meningiomas 70
Pilocytic astrocytoma: The paradigmatic entity in low‑grade gliomas (Review) 70
Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey 69
Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities 69
The role of fine-needle aspiration in the thyroid nodules of elderly patients 69
Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems 68
Assessment of cellular origin and EBV status in a PTLD after double cord blood transplantation 67
Morphological features that can predict BRAFV600E -mutated carcinoma in paediatric thyroid cytology 67
The expression of monocarboxylate transporters in thyroid carcinoma can be associated with the morphological features of BRAF V600E mutation 67
The Simultaneous Use of Bladder Epicheck® and Urinary Cytology Can Improve the Sensitivity and Specificity of Diagnostic Follow-Up of Urothelial Lesions: Up-to-Date Data from a Multi-Institutional Cohort 63
Bleeding "sarcomatosis" as a rare presentation of vascular graft-related angiosarcoma: case report and review of the literature 63
Brain Invasion along Perivascular Spaces by Glioma Cells: Relationship with Blood-Brain Barrier 62
Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection 61
Histologic Evaluation of Thyroid Nodules Treated with Thermal Ablation: An Institutional Experience 61
PD-L1 and thyroid cytology: A possible diagnostic and prognostic marker 61
To obtain more with less: cytologic samples with ancillary molecular techniques-the useful role of liquid-based cytology 61
A SPRY2 mutation leading to MAPK/ERK pathway inhibition is associated with an autosomal dominant form of IgA nephropathy 60
The Morphology of Nasal Polyps in Different Age Groups: Histopathological Features 60
Bladder Epicheck Test: A Novel Tool to Support Urothelial Carcinoma Diagnosis in Urine Samples 60
Adult and cord blood endothelial progenitor cells have different gene expression profiles and immunogenic potential 60
Protein Expression of PTTG-1, OCT-4, and KLF-4 in Seminoma: A Pilot Study 60
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer 59
The Role of Cytology in the Diagnosis of Subcentimeter Thyroid Lesions 59
DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group 59
Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphoma 59
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma 58
Update regarding the role of PD-L1 in oncocytic thyroid lesions on cytological samples 58
BRAF (V600E) MUTATION ANALYSIS ON LBC-PROCESSED ASPIRATION BIOPSIES PREDICTS BILATERALITY AND NODAL INVOLVEMENT IN PAPILLARY THYROID MICROCARCINOMA 58
Discordance in RAS mutations between primary colon tumor and metastases: a real event or a matter of methodology? 57
34BetaE12 and Alfa-Methylacyl Coenzyme A Racemase (AMACR) Antibodies Better Than p63 Antibody Distinguish Normal and Neoplastic Glands in Prostatic Tissue With Thermal Artifacts 57
Is thyroid gland only a "land" for primary malignancies? Role of morphology and immunocytochemistry 57
Morphology combined with ancillary techniques: an algorithm approach for thyroid nodules 57
Methylation study of the Paris system for reporting urinary (TPS) categories 57
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non-small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors 56
Biomarkers of response to advanced prostate cancer therapy 56
The cytologic category of oncocytic (Hurthle) cell neoplasm mostly includes low-risk lesions at histology: an institutional experience 56
The Role of thyroid fine-needle aspiration cytology in the pediatric population: an institutional experience 56
Endoscopic Ultrasound-Guided Fine-Needle Aspiration With Liquid-Based Cytologic Preparation in the Diagnosis of Primary Pancreatic Lymphoma 56
Clinical, Pathological and Prognostic Features of Rare BRAF Mutations in Metastatic Colorectal Cancer (mCRC): A Bi-Institutional Retrospective Analysis (REBUS Study) 55
A systematic review and meta-analysis of CK20, CD44, Ki67 and p53 as immunohistochemical markers in bladder carcinoma in situ 55
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer 55
Molecular testing in EBUS-TBNA specimens of lung adenocarcinoma: a study of concordance between cell block method and liquid-based cytology in appraising sample cellularity and EGFR mutations 55
A Computational Framework for Comprehensive Genomic Profiling in Solid Cancers: The Analytical Performance of a High-Throughput Assay for Small and Copy Number Variants 55
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 54
First-line ICIs in renal cell carcinoma 54
Evaluating programmed death-ligand 1 (PD-L1) in head and neck squamous cell carcinoma: concordance between the 22C3 PharmDx assay and the SP263 assay on whole sections from a multicentre study 54
DOG1 as an Immunohistochemical Marker of Acinic Cell Carcinoma: A Systematic Review and Meta-Analysis 53
A novel heterozygous HIF2AM535I mutation reinforces the role of oxygen sensing pathway disturbances in the pathogenesis of familial erythrocytosis 53
Telomerase inhibition in malignant gliomas: a systematic review 53
Prevalence of PD-L1 expression in head and neck squamous precancerous lesions: a systematic review and meta-analysis 53
The potential of liquid-based cytology in lymph node cytological evaluation: the role of morphology and the aid of ancillary techniques 53
ADAR2 Protein Is Associated with Overall Survival in GBM Patients and Its Decrease Triggers the Anchorage-Independent Cell Growth Signature 53
The BET Inhibitor OTX015 Exhibits In Vitro and In Vivo Antitumor Activity in Pediatric Ependymoma Stem Cell Models 53
Neuroimages and Neuropathology of a Stroke-Like Cerebral Lymphomatoid Granulomatosis 52
Methylation Analysis of Urinary Sample in Non-Muscle-Invasive Bladder Carcinoma: Frequency and Management of Invalid Result 52
Cytological features of micropapillary and plasmacytoid variants of urothelial carcinoma 52
Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis 52
A Novel Morphological Parameter Predicting Fibrotic Evolution in Myeloproliferative Neoplasms: New Evidence and Molecular Insights 52
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 52
Detection of ectopic thyroid remnants: a serious diagnostic dilemma. When molecular biology and immunohistochemistry can solve the problem 52
The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence? 51
Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer 51
Hypochromatic large urothelial cells in urine cytology are indicative of high grade urothelial carcinoma 51
Absence of structural mutations of the BAK gene in B cell lymphomas 51
Effect of Radio-Chemotherapy on PD-L1 Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma 50
First Case of Mature Teratoma and Yolk Sac Testis Tumor Associated to Inherited MEN-1 Syndrome 50
Concordance between Three PD-L1 Immunohistochemical Assays in Head and Neck Squamous Cell Carcinoma (HNSCC) in a Multicenter Study 50
A review of the cytomorphological features of NIFTP 50
The minefield of indeterminate thyroid nodules: could artificial intelligence be a suitable diagnostic tool? 50
Low and Ultra-Low HER2 in Human Breast Cancer: An Effort to Define New Neoplastic Subtypes 50
A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes 50
Targeting the mitogen‑activated protein kinase kinase and protein kinase A pathways overcomes acquired resistance to Selumetinib in low‑grade glioma cells 49
Deregulated expression of the imprinted DLK1-DIO3 region in glioblastoma stemlike cells: tumor suppressor role of lncRNA MEG3 49
Paths of Evolution of Progressive Anaplastic Meningiomas: A Clinical and Molecular Pathology Study 49
Immunoexpression of autophagy‑related proteins in a single‑center series of sporadic adult conventional clival chordomas 49
An abnormal secretion of soluble mediators contributes to the hematopoietic-niche dysfunction in low-risk myelodysplastic syndrome 48
Dynamic inosinome profiles reveal novel patient stratification and gender-specific differences in glioblastoma 48
Totale 6.634
Categoria #
all - tutte 44.908
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.908


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021116 0 0 0 0 0 0 65 15 12 12 0 12
2021/2022533 0 3 0 1 10 3 12 6 2 1 11 484
2022/20231.561 248 111 78 63 50 133 46 66 643 19 26 78
2023/2024693 25 55 24 68 20 27 6 32 168 108 21 139
2024/20254.228 44 34 67 192 252 124 308 676 824 198 636 873
2025/20263.062 357 568 613 573 832 119 0 0 0 0 0 0
Totale 10.197